Nimbex en es it fr

Nimbex Brand names, Nimbex Analogs

Nimbex Brand Names Mixture

  • No information avaliable

Nimbex Chemical_Formula


Nimbex RX_link

Nimbex fda sheet

Nimbex msds (material safety sheet)

Nimbex MSDS

Nimbex Synthesis Reference

No information avaliable

Nimbex Molecular Weight

929.145 g/mol

Nimbex Melting Point

185-194 oC

Nimbex H2O Solubility


Nimbex State


Nimbex LogP

No information avaliable

Nimbex Dosage Forms

Injection (10mg/mL)

Nimbex Indication

For use, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Nimbex Pharmacology

Atracurium is a nondepolarizing skeletal muscle relaxant. Atracurium can be used most advantageously if muscle twitch response to peripheral nerve stimulation is monitored to assess degree of muscle relaxation. The duration of neuromuscular block produced by Atracurium is approximately one third to one half the duration of block by d-tubocurarine, metocurine, and pancuronium at initially equipotent doses. As with other nondepolarizing neuromuscular blockers, the time to onset of paralysis decreases and the duration of maximum effect increases with increasing doses of Atracurium. Repeated administration of maintenance doses of Atracurium has no cumulative effect on the duration of neuromuscular block if recovery is allowed to begin prior to repeat dosing. Moreover, the time needed to recover from repeat doses does not change with additional doses. Repeat doses can therefore be administered at relatively regular intervals with predictable results.

Nimbex Absorption

No information avaliable

Nimbex side effects and Toxicity

Excessive doses can be expected to produce enhanced pharmacological effects. Overdosage may increase the risk of histamine release and cardiovascular effects, especially hypotension.

Nimbex Patient Information

Nimbex Organisms Affected

Humans and other mammals